en

PRODUCT DETAIL

CINQAERO 10 mg/ml infúzny koncentrát

Code 9270C
MA number EU/1/16/1125/003
Product Form: con inf 2x10 ml/100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DX Other systemic drugs for obstructive airway diseases
R03DX08 Reslizumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 16.08.2016
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 21.06.2021
eu-flag.png sk-flag.png